Meta AnalysisID 3088
21世纪（2000-2021年）LEAD的全球患病率及其与危险因素的关联：一项系统评价和Meta分析
CRD42022376447
What are the prevalences of LEAD in the general population worldwide and by region in the 21st century? What are the risk factors associated with LEAD in the general population and by region in the 21st century?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 3088
- Evidence Id
- 11646
- Core Evidence Id
- 11646
- Source Meta Analysis Id
- 3039
- Herb2 Meta Analysis Id
- HBMA003039
- Crd Id
- CRD42022376447
- Title
- Global prevalence of LEAD and its association with risk factors in the 21st century (2000-2021) a systematic review and meta-analysis
- Review Question
- What are the prevalences of LEAD in the general population worldwide and by region in the 21st century? What are the risk factors associated with LEAD in the general population and by region in the 21st century?
- Study Type Included
- Studies were included if they were published after 1st January 2000 and peripheral artery disease was defined as ABI<0.90.
- Condition Being Studied
- Lower extremity arterial disease (LEAD) is the third most common cardiovascular disease but its epidemiology is evolving. Variations of smoking habits and metabolic syndrome may affect the prevalence of LEAD in fact, while in the last century men who smoked were most at risk, in the 21st century new profiles, such as diabetics, people living in low- and middle-income countries (LMICs) and women, also appear to be at risk
- Participant
- Inclusion: Adults from the general population with a measurement of ABI. Exclusion: Participants under 18 years old.
- Animal
- Human Disease Modelled
- Intervention
- The ankle brachial index must have been measured and calculated for all study participants in order to make the diagnosis of LEAD.
- Comparator Control
- None.
- Main Outcome
- PAD is defined by an ABI<0.9 and an ABI>1.4 suggests noncompressible calcified vessel. Determine the prevalence of LEAD in the population. Measures of effect Prevalences.
- Outcome Measure
- Additional Outcome
- Hypertension, Diabetes, Dyslipidemia, Obesity and Tobacco consumption in participants with PAD. Association between risk factors and PAD. Measures of effect Odds-ratio
- Study Method
- Epidemiologic, Systematic review
- Keyword
- Humans; Prevalence; Risk Factors
- Contact
- Caroline Adou [email protected]
- Organisational Affiliation
- Institut d’Epidémiologie et de Neurologie Tropicale (IENT), EpiMaCT, U1094 Inserm U270 IRD Limoges UniversityEpiMaCT https://www.unilim.fr/ient/institut-ient/
- Funding Source
- None Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span>
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English, French
- Country
- France
- Review Stage
- Review Ongoing
- First Submission Date
- 2022-12-16
- Registration Date
- 2022-12-27
- Anticipated Start Date
- 2021-10-20
- Anticipated Completion Date
- 2023-01-20
- Title Cn
- 21世纪（2000-2021年）LEAD的全球患病率及其与危险因素的关联：一项系统评价和Meta分析
- Title En
- Global prevalence of LEAD and its association with risk factors in the 21st century (2000-2021) a systematic review and meta-analysis
- Bilingual Status
- complete